STATUTORY RULES.
1961. No. 59.
___________
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1959.*
I, THE ADMINISTRATOR of the Government of the- Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1959.
Dated this 27th day of April, 1961.
DALLAS BROOKS
Administrator.
By His Excellency's Command,
(Sgd.) Donald A. Cameron
Minister of State for Health.
__________
AMENDMENTS OF THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS.†
Commencement.
1. These Regulations shall come into operation on the first day of May,1961.
First Schedule.
2. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—
(a) by inserting after the word—
"Chloroxylenol."
the words—
"Chlortetracycline Injection."; and
(b) by omitting the word—
"Diiodohydroxyquinoline.".
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
* Notified in the Commonwealth Gazette on, 28th April 1961.
† Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102.
2700/61.—PRICE 8D. 8/20.4.1961.
Second and Third schedules.
3. The Second and Third Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—
SECOND SCHEDULE.
Regulation 10 (3.).
DRUGS AND MEDICINAL PREPARATIONS THAT ARE PHARMACEUTICAL BENEFITS ONLY WHEN PRESCRIBED FOR USE IN A DETERMINED FORM OR IN ALLOWABLE COMPOUNDS.
Pharmaceutical Benefit. | Allowable Compounds (if any). |
|
|
Acetone B.P.C.................... | Zinc Sulphate B.P. with Sulphurated Potash B.P.C., Acetone B.P.C., Glycerin B.P. and Distilled Water B.P. |
Magenta B.P.C. with Boric Acid B.P., Phenol B.P., Resorcinol B.P., Acetone B.P.C., Industrial Methylated Spirits B.P. and Water | |
Dried Aluminium Hydroxide Gel. B.P.... | Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. |
Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. | |
Aluminium Hydroxide Gel. B.P........ | Aluminium Hydroxide Gel. B.P. with Light Magnesia B.P. |
Aluminium Powder................ | Aluminium Powder with Zinc Oxide B.P. and Liquid Paraffin B.P. |
Amiphenazole Hydrobromide......... | — |
Amiphenazole Hydrochloride A.P.F. 1955. | — |
Analysis Paper (Diabetic)............ | — |
Aneurine Hydrochloride B.P. ......... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Ascorbic Acid B.P................. | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Bacitracin B.P.................... | Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base |
Bacitracin B.P. with Ophthalmic Phosphate Buffer Solution | |
Neomycin Sulphate B.P. with Bacitracin B.P. and Polymyxin B. Sulphate B.P. | |
Bendrofluazide................... | — |
Benethamine Penicillin.............. | Benthamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P. |
Benzalkonium Chloride............. | — |
Benzathine Penicillin B.P............. | Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P. |
Benzylpenicillin B.P................ | Fortified Procaine Penicillin Injection B.P. |
Benzylpenicillin B.P. with Procaine Penicillin B.P. and Stretptomycin Sulphate B.P. | |
Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P. | |
Benzylpenicillin Sodium B.P.......... | Streptomycin Sulphate B.P. with Benzylpenicillin Sodium B.P. |
Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P. | |
Bismuth Subnitrate B.P.C............ | Resorcinol B.P. with Bismuth Subnitrate B.P.C., Zinc Oxide B.P., Starch B.P., Cade Oil B.P., Wool Fat B.P., Sodium Metabisulphite, Water, Hard Paraffin B.P. and Yellow Soft Paraffin B.P. |
SECOND SCHEDULE—continued.
Pharmaceutical Benefit. | Allowable Compounds (if any). |
Busulphan...................... | — |
Butabarbital Sodium................ | — |
Carbromal B.P.................... | Pentobarbitone Sodium B.P. with Carbromal B.P. |
Chloramphenicol B.P............... | Chloramphenicol B.P. with Borate Buffer and Sterile Distilled Water |
Chloramphenicol B.P. with Propylene Glycol B.P. | |
Chloramphenicol B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. | |
Chlorpromazine Hydrochloride B.P...... | — |
Chlortetracycline Calcium............ | — |
Chlortetracycline Hydrochloride B.P..... | Chlortetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Oil of Citronella.................. | Dicophane B.P. with Emulsifying Wax B.P., Xylene B.P.C. 1949, Oil of Citronella and Water |
Clemizole...................... | — |
Cortisone Acetate B.P............... | — |
Demethylchlortetracycline Hydrochloride. | — |
Dexamethasone Sodium Phosphate...... | –– |
Dextrochlorpheniramine Maleate....... | –– |
Dicyclomine Hydrochloride........... | –– |
Dienoestrol B.P................... | –– |
Diethyl Dithiolisophthalate........... | –– |
Diiodohydroxyquinoline B.P........... | –– |
Diphenylthiourca.................. | — |
Diphtheria and Pertussis Vaccine B.P..... | Diphtheria, Tetanus and Pertussis Vaccine B.P. |
Diphtheria Vaccine B.P.............. | Diphtheria and Pertissus Vaccine B.P. |
Diphtheria, Tetanus and Pertussis Vaccine B.P. | |
Diphtheria Vaccine B.P. with Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed | |
Ergotamine Tartrate B.P.............. | Ergotamine Tartrate B.P. with Caffeine B.P. |
Erythromycin B.P.................. | –– |
Ferrous Aminoacetosulphate.......... | –– |
Ferrous Succinate................. | –– |
Guanethidine Sodium .............. | –– |
Haemophilus Influenza Bacterial Serum... | –– |
Hamamelis Dry Extract.............. | Hamamelis Dry Extract with Zinc Oxide B.P. and Theobroma Oil B.P. |
Hexocyclium Methyl Sulphate......... | — |
Hydrocortisone B.P................. | –– |
Isoprenaline Hydrochloride........... | — |
Isopropamide Iodide............... | –– |
Lofenalac....................... | — |
Mercuric Oxide Eye Ointment B.P....... | –– |
Methscopolamine Bromide ........... | –– |
Methylprednisolone................ | — |
Naphazoline Nitrate B.P.............. | Antazoline Hydrochloride B.P. with Naphazoline Nitrate B.P. |
Neomycin Sulphate B.P.............. | Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base |
Neomycin Sulphate B.P. with Bacitracin B.P. and Polymyxin B. Sulphate B.P. | |
Nicotinamide B.P. ................. | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Oestrone....................... | — |
Oleandomycin.................... | Tetracycline with Oleandomycin |
Oleoresin Capsicum................ | Bile Salts with Cascara Sagrada B.P., Phenolphthalein B.P. and Oleoresin Capsicum |
SECOND SCHEDULE—continued.
Pharmaceutical Benefit. | Allowable Compounds (if any). |
Oxyphencyclimine Hydrochloride....... | — |
Oxyphenonium Bromide............. | — |
Oxytetracycline Hydrochloride B.P....... | Oxytetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Papaveretum B.P.C................. | Papaveretum B.P.C. with Hyoscine Hydrobromide B.P. |
Pancreatin B.P.................... | — |
Pentolinium Tartrate B.P.............. | Pentolinium Tartrate B.P. with Ephedrine B.P. |
Pethidine Hydrochloride B.P........... | Pethidine Hydrochloride B.P. with Hyoscine Hydrobromide B.P. |
Pertussis Vaccine B.P................ | Diphtheria, Tetanus and Pertussis Vaccine B.P. |
Diphtheria and Pertussis Vaccine B.P. | |
Phenoxymethylpenicillin B.P........... | — |
Phenoxymethylpenicillin (Benzathine Salt). | –– |
Phenoxymethylpenicillin (Calcium Salt)... | –– |
Phenoxymethylpenicillin (Hydrabamine Salt) | — |
Phenoxymethylpenicillin (Potassium Salt).. | — |
Phenylephrine Hydrochloride B.P........ | Phenylephrine Hydrochloride B.P. with Benzocaine B.P., Bismuth Subgallate, Zinc Oxide B.P., Hamamelis Dry Extract, Tannic Acid B.P., Menthol B.P., Boric Acid B.P. and Oil of Theobroma B.P. |
Polymyxin B. Sulphate B.P............ | Polymyxin B. Sulphate B.P. with Mucilage of Methylcellulose and Distilled Water B.P. |
Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base | |
Polymyxin B. Sulphate B.P. with Ophthalmic Phosphate Buffer | |
Polymyxin B. Sulphate B.P. with Acetic Acid B.P. and Propylene Glycol B.P. | |
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Bacitracin B.P. | |
Prednisolone B.P................... | Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. |
| Prednisolone B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Prednisolone Phosphate.............. | –– |
Prednisone B.P.................... | Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. |
Procaine Hydrochloride B.P............ | Procaine Hydrochloride B.P. in Normal Saline Tetracycline and Procaine Injection B.P. |
Pyridine Aldoxime Methiodide......... | –– |
Pyrimido-Pyrimidine................ | — |
Pyrrolidino-Methyl-Tetracycline........ | — |
Rauwolfia Alkaloids ................ | — |
Reserpine B.P..................... | — |
Riboflavine B.P.................... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Sobee.......................... | — |
Sodium Chloride B.P. with Potassium Chloride B.P. and Hydrated Calcium Chloride in Water for Injection B.P. | Sodium Chloride B.P. with Potassium Chloride B.P., Hydrated Calcium Chloride B.P., Water for Injection B.P. and Dextrose B.P. |
Compound Sodium Lactate Injection B.P... | Compound Sodium Lactate Injection B.P. with Dextrose B.P. |
SECOND SCHEDULE—continued.
Pharmaceutical Benefit. | Allowable Compounds (if any). |
Sodium Lauryl Sulphate B.P........... | Emulsifying Wax B.P. |
Streptomycin Sulphate B.P............ | Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. |
Benzylpenicillin Sodium B.P. with Streptomycin Sulphate B.P. | |
Sulphadimidine B.P................. | Streptomycin Sulphate B.P. with Normal Saline |
Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P. | |
Sulphamerazine B.P................. | Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P. |
Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole | |
Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide | |
Sulphacetamide ................... | Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide |
Sulphathiazole.................... | Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole |
Terpineol B.P..................... | Solution of Chloroxylenol B.P. |
Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed | Diphtheria Vaccine B.P. with Tetanus Toxoid, |
Purified Aluminium Phosphate Adsorbed | |
Tetanus Vaccine B.P................ | Diphtheria, Tetanus and Pertussis Vaccine B.P. |
Tetracycline Hydrochloride B.P......... | Tetracycline Hydrochloride B.P. with Nystatin |
Tetracycline and Procaine Injection B.P. | |
Tetracycline Hydrochloride B.P. with a buffering agent | |
Tetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. | |
Tetracycline..................... | Tetracycline with Oleandomycin |
Thenalidine ..................... | Thenalidine with Calcium Lactate B.P. and Calcium Gluconate B.P. |
Theobroma Prepared B.P.C............ | Calcium Gluconate B.P. with Sucrose B.P., Vanillin B.P. and Theobroma Prepared B.P.C. |
Triamcinolone.................... | — |
Trifluoperazine................... | — |
Tricyclamol Chloride............... | — |
Troxidone B.P..................... | — |
Typhoid Para-Typhoid A and B Vaccine B.P. | Typhoid Para-Typhoid A, B and C Vaccine B.P. |
Tyrothricin...................... | Tyrothricin with a buffering agent |
Concentrated Vitamin A Solution B.P..... | Concentrated Vitamins A and D Solution B.P. |
Concentrated Vitamin D Solution B.P..... | Concentrated Vitamins A and D Solution B.P. |
Vitamin D....................... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Xylene B.P.C. 1949................ | Dicophane B.P. with Emulsifying Wax B.P., Xylene B.P.C. 1949, Oil of Citronella and Water |
Yellow Mercuric Oxide B.P............ | Mercuric Oxide Eye Ointment B.P. |
_______________
THIRD SCHEDULE.
Regulation 11.
PHARMACEUTICAL BENEFITS ADDITIONAL TO PHARMACEUTICAL BENEFITS IN THE BRITISH PHARMACOPOEIA. | |
Acetazolamide Sodium. | Catechu Tincture, B.P.C. |
Acetone, B.P.C. | Cetyl Alcohol Compound. |
Acetyl-Sulphamethoxypyridazine. | Charcoal. |
Aconite Liniment, B.P.C. | Chiniofon, B.P. 1948. |
Acriflavine, B.P. 1948. | Chlorambucil. |
Adrenaline Hydrochloride Solution, B.P.1953. | Chlorazanil. |
Adrenaline in Oil. | Chlormerodrin. |
Adrenaline Mucate. | Chlorpheniramine Maleate. |
Agar, B.P.C. | Chlorpropamide. |
Aloes Pill B.P. 1948. | Chlortetracycline Calcium. |
Aloin, B.P. 1953. | Chlorothiazide. |
Aloxidone. | Clemizole Hydrochloride. |
Aluminium Acetate Solution, B.P.C. | Cloves, Concentrated Infusion, B.P.C. |
Aluminium Powder. | Codeine, B.P.C. |
Amidopyrin, B.P.C. | Cod Liver Oil Emulsion, B.P. 1953. |
Amiphenazole Hydrobromide. | Colchicine Salicylate. |
Amiphenazole Hydrochloride, A.P.F. 1955. | Colocynth and Hyoscyamus Pill, B.P.C. |
Ammonium Acetate, Strong Solution, B.P. 1953. | Colocynth, B.P.C. |
Ammonium Bicarbonate, B.P. 1953. | Colocynth Compound Powder Extract, B.P.C. |
Ammonium Bromide, B.P.C. | Compound Effervescent Powder, B.P. 1953. |
Amphotericin B. | Creosote, B.P. 1953. |
Amylobarbitone Sodium, B.P.C. | Crude Coal Tar. |
Analysis Paper (Diabetic). | Cyclophosphamide. |
Androstanolone. | Cycloserine. |
Aromatic Ammonia Solution, B.P.C. | Cycrimine Hydrochloride. |
Aromatic Ammonia Spirit, B.P. 1953. | D-Cycloserine. |
Aurothioglucose. | Darrow's Solution. |
Balsam of Peru, B.P.C. | Demethylchlortetracycline Hydrochloride. |
Beeswax, Yellow, B.P.C. | Desacetyl-Lanatoside, C. |
Belladonna Suppository, B.P. 1948. | Dexamethasone. |
Bemegride, A.P.F. 1955. | Dexamethasone Sodium Phosphate. |
Bendrofluazide. | Dextran Iron. |
Benzalkonium Chloride. | Dextrin Iron. |
Benzoinated Lard, B.P.C. | Dextrochlorpheniramine Maleate. |
Bephenium Hydroxynaphthoate. | Dextrose in 1/5 Normal Saline. |
Bismuth Carbonate B.P. 1953. | Dicyclomine Hydrochloride. |
Bismuth Glycollylarsanilate. | Diethazine Hydrochloride. |
Bismuth Subgallate, B.P. 1953. | Dithiazanine Iodide. |
Bismuth Subnitrate, B.P.C. | Diethyl Dithiolisophthalate. |
Bretylium Tosylate. | Digitoxin, B.P.C. |
Buchu Concentrated Infusion, B.P.C. | Dihydroergotamine. |
Busulphan. | Dihydromorphinone Hydrochloride, B.P.C. 1949. |
Butabarbital Sodium. | Dihydrotachysterol. |
Butyl Aminobenzoate, B.P. 1953. | Diphenylthiourea. |
Caffeine Citrate. B.P.C. | Diphtheria Toxoid Purified. |
Cajuput Tincture, B.P.C. | Disodium Dicthylstilboestrol Diphosphate. |
Calamine Cream, A.P.F. | Disodium Dihydrogen Versenate. |
Calcium Aurothiomalate. | Ephedrine Sulphate, B.P.C. |
Calcium Di-Oxytetracycline. | Ergot Liquid Extract, B.P.C. |
Calcium Para-Aminosalicylate, B.P.C. | Erythrityltetranitrate, B.P.C. 1949. |
Calcium Phosphate, B.P. 1953. | Erythromycin Glucoheptonate. |
Calumba Concentrated Infusion, B.P. 1948. | Erythromycin Propionate. |
Calumba Tincture, B.P. 1948. | Erythromycin Stearate. |
Capsicum Ointment. B.P.C. | Ether Nitrous Spirit, B.P.C. |
Capsicum Tincture. B.P.C. |
|
Caramiphen Hydrochloride. |
|
Cardamom Aromatic Tincture, B.P.C. |
|
|
|
|
|
|
|
|
|
THIRD SCHEDULE—continued.
Ferrous Phosphate Compound Syrup, B.P.C. | Nystatin. |
| Oestradiol Dipropionate. |
Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C. | Oestrone. |
| |
| Oleandomycin. |
Ferrous Succinate. | Oleoresin Capsicum. |
Fludrocortisone Acetate. | Orange Peel Infusion Concentrated, B.P. 1948. |
Fluoxymesterone. |
|
Formyl-Tetrahydropteroyl Glutamic Acid. | Orange Peel infusion Concentrated, |
Fructose, B.P. 1948. | Compound, B.P.C. |
Gall with Opium Ointment, B.P.C. | Ox-Bile Extract, B.P., 1948 |
Gelesmium Tincture, B.P.C. | Oxymel, B.P.C. |
Gentian Violet. | Oxymel of Squill, B.P.C. |
Glucose Liquid, B.P. 1953. | Oxyphencyclimine Hydrochloride. |
Glycerophosphates Compound Syrup, A.P.F. | Oxyphenonium Bromide. |
| Oxytetracycline I.M. |
Guanethidine Sodium. | Pancrex 5. |
Haemophilus Influenza Bacterial Serum. | Para-Aminosalicyclic Acid. |
Hamamelis Dry Extract. | Paraben Ophthalmic Phosphate Buffer, A.P.F. |
Heparin Retard. |
|
Hexachlorophene, 3% with Entsufon. | Paraben Ophthalmic vehicle, A.P.F. |
Hexachlorothiazide. | Papaveretum, B.P.C. |
Hexocyclium Methyl Sulphate. | Benzylpenicillin in Oil. |
Hexoestrol. | Penicillin Benethamine. |
Hydrocortisone Sodium Succinate. | Penicillinase. |
Hydrocyanic Acid Dilute, B.P.C. | Pentacrythritol Tetranitrate. |
Hydroflumethiazide. | Pertussis Prophylactic (Haemagglutinin Aluminium Phosphate Adsorbed). |
Hydroxychloroquine Sulphate. | |
Hypophosphorous Acid Dilute, B.P.C. | Phemitone, B.P. 1953. |
Insulin Isophane (N.P.H.). | Phenazone, B.P.C. |
Insulin Special P (Pig). | Phenoxymethylpenicillin (Benzathine Salt). |
Iodochlorhydroxyquinoline. | Phenoxymethylpenicillin (Calcium Salt). |
Iodoform B.P.C. | Phenoxymethylpenicillin (Potassium Salt). |
Iodoform Suppository, B.P. 1948. | Phenoxymethylpenicillin (Hydrabamine Salt). |
Ipomoea Resin. | Phensuximide. |
Iron Carbonate Saccharated, B.P.C. | Phenylbutazone. |
Iron Oxide Saccharated. | Phthalysulphacetamide. |
Isoprenaline Hydrochloride. | Pholcodine, B.P.C. |
Isopropamide Iodide. | Pholcodine Citrate Syrup, B.P.C. |
Lobelia Ethereal Tincture, B.P.C. | Piperazine Citrate. |
Lofenalac. | Pituitary (Posterior Lobe). |
Magenta, B.P.C. | Potash Sulphurated, B.P.C. |
Magnesium Bicarbonate Solution, B.P 1948. | Potassium Chlorate, B.P.C. |
Mecamylamine. | Prednisolone Phosphate. |
Mecholyl Chloride. | Prednisolone Sodium Hemisuccinate. |
Mercaptomerin Sodium. | Probenecid. |
Mercaptopurine. | Prophenpyridamine Para-Aminosalicylate. |
Mercuric Chloride, B.P. 1953. | Protamine Sulphate. |
Mercurous Chloride Ointment, B.P. 1948. | Protoveratrines A. |
Mercury Compound Ointment, B.P.C. | Pyridine Aldoxime Methiodide. |
Methenamine Mandelate. | Pyridostigmine Bromide. |
Methorphinan. | Pyridoxine Hydrochloride, B.P.C. |
Methotrexate. | Pyrimido-Pyrimidine. |
Methscopolamine Bromide. | Pyrrolidino-Methyl-Tetracycline. |
Methyl Androstanolone. | Quassia Tincture, B.P. 1948. |
Methyl Atropine Nitrate. | Rauwolfia Alkaloids. |
Methyl Prednisolone. | Ristocetin. |
Methylandrostenediol. | Salicylazosulphapyridine. |
Myrrh, B.P.C. | Senega Concentrated Infusion, B.P.C. |
Myrrh Tincture, B.P.C. | Senna Compound Mixture, B.P.C. |
Nicoumalone. | Senna Leaf Concentrated Infusion, B.P.C. |
Nitrofurantoin. | Siberian Fir Oil, B.P.C. 1949. |
Nitromin. | Silver Picrate, B.P.C. 1949. |
Norethandrolone. | Silver Protein Mild, B.P.C. |
Nux Vomica Extract, Dried, B.P. 1953. | Soap Curd, B.P.C. |
THIRD SCHEDULE—continued.
Soap Hard, B.P.C. | Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed. |
Sobee. | |
Sodium Calcium Edetate. | Tetracycline. |
Sodium Carbonate Exsiccated, B.P.C. | Thenalidine. |
Sodium Folate. | Theobromine, B.P.C. |
Sodium Lactate. | Theobroma Prepared, B.P.C. |
Sodium Nitrite, B.P.C. | Thiacetazone. |
Sodium Oleate Acid. | Thiouracil, B.P. 1948. |
Sodium Tauroglycocholate. | Thyrotropin. |
Sorbolene, A.P.F. | Tiger Snake Antivenene. |
Spiramycin. | Tolbutamide. |
Squill Tincture. | Tretamine. |
Squill Vinegar, B.P. 1948. | Triamcinolone. |
Strophantus Tincture, B.P. 1948. | Tricyclamol Chloride. |
Strychnine, B.P.C. | Triethanolamine Trinitrate. |
Sulphacetamide. | Triethylene Thiophosphoramide. |
Sulphadiazine Sodium. | Trifluoperazine. |
Sulphadimethoxine. | Trimetaphan Camphorsulphonate. |
Sulphamethoxypyridazine. | Trinitrophenol, B.P.C. |
Sulphafurazole. | Tripolidine Hydrochloride. |
Sulphamethizole. | Tyrothrycin. |
Sulphaphenazole. | Valerian Ammoniated Tincture, B.P.C. |
Sulphathiazole. | Vasopressin Tannate in Oil. |
Sulphapyridine, B.P.C. | Veriloid. |
Sulphuric Acid Dilute, B.P.C. | Vitamin A. |
Syntocinon. | Vitamin D. |
Talc Purified, B.P.C. | Vitamin K1. |
Testosterone Oenanthate. | Xylene, B.P.C. 1949. |
Fifth Schedule.
4. The Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations is repealed and the following Schedule inserted in its stead:—
FIFTH SCHEDULE.
Regulation 14.
PHARMACEUTICAL BENEFITS THE PRESCRIBING OF WHICH IS SUBJECT TO CONDITIONS AND RESTRICTIONS.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
|
|
| As an antidote to barbiturate and other hypnotic poisons |
Amiphenazole Hydrochloride A.P.F. 1955 | |
Amphotericin B ...................... | Systemic fungal infections |
Androstanolone ...................... | Mammary carcinoma |
Aneurine Hydrochloride Tablets B.P.......... | Any disease or condition in a pensioner |
Ascorbic Acid Tablets B.P................ | Any disease or condition in a Pensioner |
Bemegride A.P.F. 1955.................. | As an antidote to barbiturate and other hypnotic poisons |
Busulphan .......................... | The leukaemias |
Calciferol Tablets B.P................... | Any disease or condition in a pensioner |
Calciferol Solution B.P.................. | Any disease or condition in a child under the age of twelve years or in a pensioner |
Calcium Para-Aminosalicylate B.P.C......... | Tuberculosis |
Caramiphen Hydrochloride............... | Parkinsonism |
Chlorambucil ........................ | Malignant lymphoma and related conditions |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whoso treatment it may be prescribed) for supply under Part VII. of the Act. |
Chloramphenicol Capsules B.P..... | Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate |
Bacterium coli meningitis, if other forms of treatment are unsuccessful | |
Brucellosis | |
Granuloma inguinale | |
Friedlander bacillus infection | |
Haemophilus influenzae infections | |
Laryngo-tracheo-bronchitis, acute | |
Lymphogranuloma venereum | |
Salmonella infections | |
Staphylococcal infections | |
Surgical conditions of the bowel (pre-operative and post-operative) | |
Typhoid fever | |
Typhus and other rickettsial diseases | |
Urinary tract infections due to gram negative bacilli that arc resistant to the Sulphonamides | |
Whooping cough (Haemophilus pertussis) | |
As an alternative to the Penicillins in a person sensitive to the Penicillins | |
Severe gastro-enteritis in a child under the age of sixteen years | |
Chloramphenicol B.P., Injection ..... | A disease or condition specified in this column in relation to Chloramphenicol Capsules |
Chloramphenicol B.P., Oral Suspension | A disease or condition, specified in this column in relation to Chloramphenicol Capsules, in a child under the age of twelve years |
Chlortetracycline Capsules B.P. ..... | As an alternative to the Penicillins in a person sensitive to the Penicillins |
Actinomycosis | |
Amoebiasis | |
Bacterial endocarditis (Streptococcus faecalis), acute and sub-acute | |
Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate | |
Bronchiectasis | |
Brucellosis | |
Chancroid | |
Fibrocystic disease of the pancreas | |
Granuloma inguinale | |
Friedlander bacillus infections | |
Leptospirosis | |
Lymphogranuloma venereum | |
Mucoviscidosis | |
Pneumonia that is resistant both to the Penicillins and the Sulphonamides | |
Primary atypical pneumonia | |
Psittacosis | |
Puerperal infections | |
Rat-bite fever (Spirillum minus) | |
Staphylococcal infections | |
Trachoma that is resistant to the Sulphonamides | |
Typhus and other rickettsial diseases | |
Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides | |
Whooping cough (Haemophilus pertussis) |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part vii. of the Act. |
| A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years |
Chlortetracycline B.P., Granules.... | |
| Any disease or condition in a child under the age of twelve years or in a pensioner |
Cod Liver Oil Emulsion B.P. 1953... | |
Corticotrophin Injection B.P....... | With the written authority of the Director-General— |
A disease or condition specified in this column in relation to Cortisone Acetate | |
The treatment of side effects of corticosteroid therapy | |
Cortisone Injection B.P.......... | With the written authority of the Director-General— |
Anaemia, acquired haemolytic | |
Addison's disease and other forms of adrenocortical hypoplasia | |
Adrenalectomy, total | |
Adrenogenital syndrome | |
Cranial arteritis | |
Cushing's syndrome, including hyperadrenocorticalism | |
Dermatitis, acute exfoliative, associated with drug therapy | |
Dermatomyositis | |
Encephalomyelitis | |
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis proven by lung biopsy | |
Hansen's disease | |
Hepatitis, progressive or continuing, proven by biopsy or biochemistry | |
The leukaemias | |
Nephritis, type II. | |
Nephrotic syndrome | |
Neuro-myelitis optica | |
Optic neuritis following removal of tumor of the brain | |
Panhypopituitarism | |
Pemphigus | |
Periarteritis nodosa | |
Pseudohermaphroditism | |
Purpura, Henoch's | |
Purpura, thrombocytopenic | |
Rheumatic carditis, acute | |
Salaam convulsions and hypsarrythmia | |
Sarcoidosis | |
Scleroderma | |
Splenic neutropenia and agranulocytosis | |
Status asthmaticus | |
Steroid therapy prior to operation in patients under steroid therapy | |
Still's disease in a child under the age of sixteen years | |
Sympathetic ophthalmitis | |
Systemic lupus erythematosus | |
Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases | |
Ulcerative colitis proven by sigmoidoscopy or radiological report | |
Uveitis, posterior |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Cortisone Tablets B.P........... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Cyanocobalamin Injection B.P. (other than 1,000 microgramme strength) | Established megalocytic anaemias
|
Cyanocobalamin Injection B.P., 1,000 microgramme strength | Neuroblastoma |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
Cycloserine.................. | |
D-Cycloserine................ | |
Demethylchlortetracycline Hydrochloride | A disease or condition specified in this column in relation to Chlortetracycline Capsules |
|
|
Deoxycortone Acetate Injection B.P.. | Total adrenalectomy |
Deoxycortone Acetate Implant B.P.. | |
| With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Dexamethasone Sodium Phosphate.. | |
Dienoestrol B.P., Cream ......... | Any disease or condition in a pensioner |
Dienoestrol Tablets B.P.......... | Carcinoma of the prostate |
Mammary carcinoma | |
Any disease or condition in a pensioner | |
Diethyl Dithiolisophthalate....... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Diiodohydroxyquinoline B.P., Vaginal Tablet | Trichomonal and monilial vaginitis |
Dihydrostreptomycin Sulphate Injection B.P. | As an alternative to Streptomycin Sulphate in a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate |
Dihydrotachysterol............. | Parathyroid deficiency |
Diphenylthiourea.............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Disodium Diethylstilboestrol Diphosphate | Carcinoma of the prostate |
| Staphylococcal infections that arc resistant both to the Tetracyclines and to the Penicillins |
Erythromycin Tablets B.P......... | |
Erythromycin Glucoheptonate..... | |
| |
Erythromycin B.P., Oral Suspension. | Staphylococcal infections that arc resistant both to the Tetracyclines and to the Penicillins in a child under the age of twelve years |
Erythromycin Stearate, Oral Suspension | |
Ethinyloestradiol Tablets B.P....... | Turner's syndrome |
Pre-menopausal castration | |
Any disease or condition in a pensioner | |
Ethisterone Tablets B.P.......... | Turner's syndrome |
Habitual abortion | |
Any disease or condition in a pensioner | |
| Any disease or condition in a child under the age of twelve years |
Ferrous Succinate Syrup......... | |
Fludrocortisone Acetate.......... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
|
|
Folic Acid B.P................ | Macrocytic anaemia |
Folic Acid Tablets B.P.......... | Sprue or the sprue-like syndrome |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
Haemophilus Influenza Bacterial Serum. | |
Hexachlorophene, 3% with Entsufon... | |
Hydrocortisone Injection B.P........ | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Hydrocortisone Sodium Succinate..... | Acute adrenal failure due to a medical or surgical crisis |
Stevens Johnson syndrome | |
Iron Oxide Saccharated............ | As an alternative to Oral Iron in a person unable to take Oral Iron |
Isoniazid Tablets B.P.............. | Hansen's disease |
Tuberculosis | |
Lofenalac..................... | With the written authority of the Director-General, phenylketonuria |
| Any disease or condition in a child under the age of twelve years or in a pensioner |
Malt Extract with Cod Liver Oil B.P.... | |
Mercaptopurine................. | The leukaemias |
Methorphinan.................. | Inoperable cancer |
Methotrexate................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Methyl Androstanolone............ | Mammary carcinoma |
Methylandrostenediol............. | Senile osteoporosis proven by radiography |
Mustine Injection B.P............. | Malignant lymphoma and related conditions |
Nicotinamide Tablets B.P........... | Any disease or condition in a pensioner |
Nicotinic Acid Tablets B.P.......... | Any disease or condition in a pensioner |
Nitrofurantoin.................. | Urinary tract infections |
Nitromin...................... | Malignant lymphoma and related conditions |
Norethandrolone................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Nystatin...................... | Proven monilia infections |
| A disease or condition specified in this column in relation to Chlortetracycline Capsules |
Oxytetracycline Injection B.P......... | |
Oxytetracycline and Procaine Injection B.P. | |
Oxytetracycline J.M.............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Calcium Di-Oxytetracycline......... | A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years |
Pancreatin B.P.................. | Fibrocystic disease of the pancreas |
Pancreatico-duodenectomy | |
Pancrex 5..................... | Fibrocystic disease of the pancreas |
Pancreatico-duodenectomy | |
Para-Aminosalicyclic Acid.......... | Tuberculosis |
| Any disease or condition in a child under the age of twelve years |
Phenoxymethylpenicillin (Benzathine Salt), Oral Suspension | |
Phenoxymethylpenicillin(Calcium Salt), Oral Suspension | |
Phenoxymethylpenicillin(Hydrabamine Salt), Oral Suspension | |
Phenoxymethylpenicillin (Potassium Salt), Oral Suspension | |
Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. | Endocarditis due to Streptococcus faecalis or Streptococcus viridans |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Prednisolone Tablets B.P........... | With the written authority of the Director-General— |
Anaemia, acquired haemolytic | |
Adrenogenital syndrome | |
Cranial arteritis | |
Cushing's syndrome, including hyperadrenocorticalism | |
Dermatitis, acute exfoliative, associated with drug therapy | |
Dermatomyositis | |
Encephalomyelitis | |
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis proven by lung biopsy | |
Hansen's disease | |
Hepatitis, progressive or continuing, proven by biopsy or biochemistry | |
The leukaemias | |
Nephritis, type II. | |
Nephrotic syndrome | |
Neuro-myelitis optica | |
Optic neuritis following removal of tumour of the brain | |
Panhypopituitarism | |
Pemphigus | |
Periarteritis nodosa | |
Pseudohermaphroditism | |
Purpura, Henoch's | |
Purpura, thrombocytopenic | |
Rheumatic carditis, acute | |
Salaam convulsions and hypsarrythmia | |
Sarcoidosis | |
Scleroderma | |
Splenic neutropenia and agranulocytosis | |
Status asthmaticus | |
Steroid therapy prior to operation in patients under steroid therapy | |
Still's disease in a child under the age of sixteen years | |
Sympathetic ophthalmitis | |
Systemic lupus erythematosus | |
Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases | |
Ulcerative colitis proven by sigmoidoscopy or radiological report | |
Uveitis, posterior | |
Methyl Prednisolone.............. | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets |
| With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. | |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
Prednisone Tablets B.P............ | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Progesterone Injection B.P........... | Habitual abortion |
Protoveratrines A................ | Hypertensive crisis |
Pyridine Aldoxime Methiodide....... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Pyridostigmine Bromide........... | Myasthenia gravis |
Riboflavine Tablets B.P............ | Any disease or condition in a pensioner |
Ristocetin..................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Salicylazosulphapyridine........... | Ulcerative colitis |
Sobee........................ | With the written authority of the Director-General, galactosaemia |
| Tuberculosis |
Sodium Aminosalicylate Tablets B.P.... | |
Sodium Folate.................. | Macrocytic anaemia |
Sprue or the sprue-like syndrome | |
|
|
Stilboestrol Tablets B.P............ | Mammary carcinoma |
Any disease or condition in a pensioner | |
| Bacillary dysentery that is resistant to the Sulphonamides |
Brucellosis | |
Chancroid | |
Endocarditis due to Streptococcus faecalis or Streptococcus viridans | |
Friedlander bacillus infections | |
Haemophilus influenzae infections | |
Plague | |
Pseudomonas pyocyaneus infections | |
Rat-bite fever (Streptobacillus moniliformis) | |
Salmonella infections | |
Surgical conditions of the bowel (pro-operative and post-operative) | |
Surgical conditions of the thoracic organs | |
Tuberculosis | |
Tularaemia | |
Urinary tract infections that are resistant to the Sulphonamides | |
Streptomycin Sulphate Injection B.P.... | A disease or condition specified in this column in relation to Streptomycin Sulphate |
Streptomycin Sulphate B.P. with Benzylpenicillin Sodium. B.P. | Endocarditis due to Streptococcus faecalis or Streptococcus viridans |
|
|
Sustanon...................... | Castration |
Testosterone Implants B.P.......... | Mammary carcinoma |
Testosterone Oenanthate........... | |
|
|
Testosterone Propionate B.P......... | Kline felter Reifenstein Albright syndrome |
Methyltestosterone Tablets B.P........ | Mammary carcinoma |
| A disease or condition specified in this column in relation to Chlortetracycline Capsules |
Tetracycline Tablets B.P........... | |
Tetracycline and Procaine Injection B.P. | |
Tetracycline Hydrochloride B.P. with a buffering agent—Capsules | |
Tetracycline with Oleandomycin Capsules | |
Pyrrolidino-Methyl-Tetracycline |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
| A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years |
Tetracycline Hydrochloride B.P. with a buffering agent—Oral Suspension | |
Tetracycline Hydrochloride B.P. with a buffering agent—Paediatric Drops | |
Tetracycline with Oleandomycin—Oral Suspension | |
Tetracycline Hydrochloride B.P. with Nystatin | Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis |
A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules | |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
Triethylene Thiophosphoramide...... | |
Tretamine..................... | Malignant lymphoma and related conditions |
Trifluoperazine.................. | Any disease or condition in a pensioner |
Trimetaphan Camphorsulphonate.. | Hypotensive for anaesthesia |
Veriloid...................... | Hypertensive crisis |
Vitamin A Activity with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D | Any disease or condition in a pensioner |
| Any disease or condition in a child under the age of twelve years or in a pensioner |
Concentrated Vitamin A and D Solution B.P. | |
Concentrated Vitamin D Solution..... | |
Vitamin K1.................... | As an antidote to anticoagulants |
_________________________
By Authority: A. J. ARTHUR, Commonwealth Government Printer, Canberra.